Bearish flow noted in INmune Bio (INMB) with 1,880 puts trading, or 1.1x expected. Most active are Jul-25 2.5 puts and Jul-25 5 puts, with total volume in those strikes near 1,700 contracts. The Put/Call Ratio is 2.81, while ATM IV is up nearly 4 points on the day. Earnings are expected on July 31st.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INMB:
- Inmune Bio’s Phase 2 Trial of XPro: Anticipated Catalyst for Stock Surge Amid Robust Design and High Short Interest
- Largest borrow rate increases among liquid names
- INmune Bio Collaborates on TBI and Alzheimer’s Study
- INmune Bio initiated with a Buy at Lucid Capital
- INmune Bio to Attend RBC Healthcare Conference